-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We trim our 12-month target price by $3 to $43. We value AB shares at 10.8x our 2027 EPS estimate of $4.00 (lowered by $0.20) and 11.8x our 2026 EPS estimate of $3.65 (trimmed by $0.15). This compares with the one-year average forward multiple of 11.4x and a disparate peer average of 16x. AB shares represent partnership interests and currently yield 8.8%. We keep our 2026 revenue growth forecast of 3% to 7%. Q1 adjusted revenues rose 3.9% to $871M, in line with our forecast. AB noted its institutional pipeline totaled $27.5B at the end of Q1. The pipeline is set to benefit from strategic initiatives, including the planned expansion into Asia insurance markets. AUM grew 6.9% to $838.6B. However, net outflows deteriorated to $7.1B (from $2.4B of inflows a year ago), masking $6.7B of inflows into fixed income, alternatives, and multi-asset investments. Driven by restructuring actions, GAAP operating margins expanded 430 bps to 26.1%. We see additional operating margin expansion in 2026.